Scanning and combinatorial library services – Save 20% with code TRY-BXPLIB-20

Synthetic Biology for Accelerated Vaccine Discovery

Synthetic Biology for Accelerated Vaccine Discovery

Automated synthetic biology workflows enable efficient mRNA-based therapeutic development

Decades of mRNA research and advances in nanotechnology led to mRNA vaccine development and approval during the COVID-19 pandemic. However, realizing the full potential of mRNA-based therapeutics requires optimizing the discovery pipeline. In this webinar brought to you by Telesis Bio, (formerly Codex DNA), Krishna Kannan will discuss how innovations in synthetic biology automation improve the mRNA workflow and accelerate vaccine development.

Topics to be covered

  • Synthesizing mRNA candidates overnight
  • Automating mRNA synthesis for accelerated vaccine design
  • Streamlining the synthetic biology workflow for optimal efficiency and control during mRNA therapeutic development


Krishna Kannan

Krishna Kannan, PhD
Senior Director of Product Development
Telesis Bio

Sponsored by

Telesis Bio

Contact us

The expertise of our scientists, engineers and supporting teams are at your service! Submit the form below and/or call us at 858.526.3080.

"*" indicates required fields

This field is for validation purposes and should be left unchanged.

By clicking Submit, you agree that Telesis Bio may use this information to contact you about our programs, products, or services. You may opt out at any time.

Your personal data is handled according to our privacy policy. In addition, if you are located within a distributor territory, you may be contacted directly by them. We never sell your data to anyone.